The impact of antimalarial resistance on the genetic structure of Plasmodium falciparum in the DRC
Robert Verity, Ozkan Aydemir, Nicholas F. Brazeau, Oliver J. Watson, Nicholas J. Hathaway, Melchior Kashamuka Mwandagalirwa, Patrick W. Marsh, Kyaw Thwai, Travis Fulton, Madeline Denton, Andrew P. Morgan, Jonathan B. Parr, Patrick K. Tumwebaze, Melissa Conrad, Philip J. Rosenthal, Deus S. Ishengoma, Jeremiah Ngondi, Julie Gutman, Modest Mulenga, Douglas E. Norris, William J. Moss, Benedicta A. Mensah, James L. Myers-Hansen, Anita Ghansah, Antoinette K. Tshefu, Azra C. Ghani, Steven R. Meshnick, Jeffrey A. Bailey, Jonathan J. Juliano
April 2020Antimalarials
Chloroquine
Democratic Republic of the Congo
Drug Combinations
Drug Resistance
Genome
Protozoan
Genotype
Geography
Haplotypes
Humans
Malaria
Falciparum
Mutation
Plasmodium falciparum
Polymorphism
Single Nucleotide
Principal Component Analysis
Pyrimethamine
Sulfadoxine
Related
- Spatial and epidemiological drivers of Plasmodium falciparum malaria among adults in the Democratic Republic of the Congo
- Selection of Cytochrome b Mutants Is Rare among Plasmodium falciparum Patients Failing Treatment with Atovaquone-Proguanil in Cambodia
- Household Prevalence of Plasmodium falciparum, Plasmodium vivax, and Plasmodium ovale in the Democratic Republic of the Congo, 2013-2014
- Partner-Drug Resistance and Population Substructuring of Artemisinin-Resistant Plasmodium falciparum in Cambodia
- The Burden of Malaria in the Democratic Republic of the Congo